INSP
Inspire Medical Systems Inc.
$72.08
-$0.99(-1.35%)
43
Overall
30
Value
45
Tech
55
Quality
Market Cap
$2.36B
Volume
1.77M
52W Range
$70.77 - $216.01
Target Price
$119.07
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $50.6M | $82.0M | $115.4M | $233.4M | $407.9M | $624.8M | $802.8M | ||
| Total Revenue | $50.6M | $82.0M | $115.4M | $233.4M | $407.9M | $624.8M | $802.8M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $10.1M | $13.6M | $17.6M | $33.3M | $66.1M | $96.6M | $123.0M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $40.5M | $68.4M | $97.8M | $200.1M | $341.7M | $528.2M | $679.8M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $60.9M | $103.3M | $154.0M | $240.0M | $389.3M | $568.5M | $643.7M | ||
| Research & Development | $7.4M | $12.8M | $26.1M | $37.4M | $68.6M | $116.5M | $114.1M | ||
| Research Expense | $7.4M | $12.8M | $26.1M | $37.4M | $68.6M | $116.5M | $114.1M | ||
| Selling, General & Administrative | $53.5M | $90.5M | $127.9M | $202.6M | $320.7M | $452.0M | $529.6M | ||
| Selling & Marketing Expenses | $53.5M | $18.0M | $26.4M | $47.8M | $74.3M | $100.3M | $94.9M | ||
| General & Administrative Expenses | $-200.0K | $90.5M | $127.9M | $202.6M | $320.7M | $452.0M | $529.6M | ||
| Promotion & Advertising | $-7.8M | $18.0M | $26.4M | $47.8M | -- | $100.3M | $94.9M | ||
| Salaries & Wages | $-52.8M | $35.3M | $54.8M | $58.4M | -- | -- | -- | ||
| Depreciation & Amortization | $-400.0K | $500.0K | $800.0K | $1.2M | $1.9M | $2.8M | $6.6M | ||
| Depreciation & Amortization | $-400.0K | $500.0K | $800.0K | $1.2M | -- | -- | -- | ||
| Other Operating Expenses | -- | $-40.0K | -- | $-49.0K | -- | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $-20.4M | $-34.9M | $-56.2M | $-39.9M | $-47.6M | $-40.3M | $36.1M | ||
| EBITDA | $-18.2M | $-31.3M | $-54.1M | $-38.6M | $-40.7M | $-17.1M | $65.0M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $3.3M | $2.1M | $2.1M | $2.1M | $1.7M | -- | $22.0K | ||
| Intinc | $1.9M | $3.8M | $1.1M | $125.0K | $5.0M | $20.6M | $23.2M | ||
| Net Non-Operating Interest Income/Expense | $-1.4M | $1.7M | $-1.0M | $-2.1M | $-3.4M | $20.6M | $23.2M | ||
| Gain on Sale of Securities | -- | $154.0K | $-73.0K | $-84.0K | $-120.0K | $746.0K | $-199.0K | ||
| Other Income/Expense | $16.0K | $-166.0K | $-72.0K | $76.0K | $-49.0K | $-551.0K | $1.1M | ||
| Other Special Charges | $-16.0K | $12.0K | $145.0K | $8.0K | $-49.0K | $-195.0K | $-855.0K | ||
| SPECIAL ITEMS | |||||||||
| Special Income Charges | -- | $-13.6M | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-18.5M | $-31.1M | $-55.0M | $-39.8M | $-42.6M | $-19.9M | $58.5M | ||
| Pre-Tax Income | $-21.8M | $-33.2M | $-57.1M | $-42.0M | $-44.3M | $-19.9M | $58.5M | ||
| INCOME TAX | |||||||||
| Tax Provision | -- | $40.0K | $115.0K | $72.0K | $613.0K | $1.2M | $4.9M | ||
| NET INCOME | |||||||||
| Net Income | $-21.8M | $-33.2M | $-57.2M | $-42.0M | $-44.9M | $-21.2M | $53.5M | ||
| Net Income (Continuing Operations) | $-21.8M | $-33.2M | $-57.2M | $-42.0M | $-44.9M | $-21.2M | $53.5M | ||
| Net Income (Discontinued Operations) | $-21.8M | $-33.2M | $-57.2M | $-42.0M | $-44.9M | $-21.2M | $53.5M | ||
| Net Income (Common Stockholders) | $-21.8M | $-33.1M | $-57.2M | $-42.0M | $-44.9M | $-21.2M | $53.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $57.9M | ||
| TOTALS | |||||||||
| Total Expenses | $71.0M | $116.9M | $171.6M | $273.2M | $455.4M | $665.1M | $766.7M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $14.6M | $23.8M | $26.1M | $27.3M | $28.1M | $29.3M | $29.8M | ||
| Average Shares Outstanding (Diluted) | $14.6M | $23.8M | $26.1M | $27.3M | $28.1M | $29.3M | $30.5M | ||
| Shares Outstanding | $23.4M | $24.1M | $27.1M | $27.5M | $29.0M | $29.6M | $29.7M | ||
| Basic EPS | -- | $-1.4 | $-2.19 | $-1.54 | $-1.6 | $-0.72 | $1.8 | ||
| Basic EPS (Continuing Operations) | -- | $-1.4 | $-2.19 | $-1.54 | $-1.6 | $-0.72 | $1.8 | ||
| Diluted EPS | $-1.5 | $-1.4 | $-2.19 | $-1.54 | $-1.6 | $-0.72 | $1.75 | ||
| Diluted EPS (Continuing Operations) | $-1.5 | -- | -- | $-1.54 | $-1.6 | $-0.72 | $1.75 | ||
| OTHER METRICS | |||||||||
| Other Gand A | $-200.0K | $90.5M | $127.9M | $202.6M | $320.7M | $452.0M | $529.6M | ||
| Rent And Landing Fees | $-200.0K | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $53.5M | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | $13.6M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSP | $72.08 | -1.4% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inspire Medical Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW